Vericel Corp. (VCEL)
42.36
-0.32
(-0.76%)
USD |
NASDAQ |
Aug 24, 16:00
42.36
0.00 (0.00%)
After-Hours: 19:19
Vericel 1 Year Total Returns (Daily) : 20.43% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 20.43% |
| August 20, 2026 | 19.09% |
| August 19, 2026 | 20.46% |
| August 18, 2026 | 21.86% |
| August 17, 2026 | 20.15% |
| August 14, 2026 | 23.57% |
| August 13, 2026 | 17.43% |
| August 12, 2026 | 22.41% |
| August 11, 2026 | 25.18% |
| August 10, 2026 | 21.27% |
| August 07, 2026 | 24.73% |
| August 06, 2026 | 23.31% |
| August 05, 2026 | 23.19% |
| August 04, 2026 | 23.31% |
| August 03, 2026 | 29.24% |
| July 31, 2026 | 31.54% |
| July 30, 2026 | 17.09% |
| July 29, 2026 | 16.96% |
| July 28, 2026 | 12.69% |
| July 27, 2026 | 12.96% |
| July 24, 2026 | 13.42% |
| July 23, 2026 | 11.64% |
| July 22, 2026 | 17.32% |
| July 21, 2026 | 30.12% |
| July 20, 2026 | 29.82% |
| Date | Value |
|---|---|
| July 17, 2026 | 28.63% |
| July 16, 2026 | 28.80% |
| July 15, 2026 | 25.93% |
| July 14, 2026 | 15.75% |
| July 13, 2026 | 18.93% |
| July 10, 2026 | 13.99% |
| July 09, 2026 | 16.41% |
| July 08, 2026 | 17.05% |
| July 07, 2026 | 19.13% |
| July 06, 2026 | 11.55% |
| July 02, 2026 | 13.31% |
| July 01, 2026 | 8.53% |
| June 30, 2026 | 4.56% |
| June 29, 2026 | 8.00% |
| June 26, 2026 | 10.97% |
| June 25, 2026 | 2.44% |
| June 24, 2026 | -3.81% |
| June 23, 2026 | -3.37% |
| June 22, 2026 | -3.69% |
| June 18, 2026 | -4.02% |
| June 17, 2026 | -5.71% |
| June 16, 2026 | -7.53% |
| June 15, 2026 | -10.26% |
| June 12, 2026 | -11.82% |
| June 11, 2026 | -12.70% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Krystal Biotech, Inc. | 137.9% |
| AbbVie, Inc. | 30.40% |
| Marker Therapeutics, Inc. | 14.88% |
| TG Therapeutics, Inc. | 88.63% |
| ADMA Biologics, Inc. | -42.46% |